Catheter Precision Reports Material Agreements and Acquisition
Ticker: VTAK · Form: 8-K · Filed: May 8, 2025 · CIK: 1716621
| Field | Detail |
|---|---|
| Company | Catheter Precision, Inc. (VTAK) |
| Form Type | 8-K |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, acquisition, debt, equity-sale
TL;DR
CPCI filed an 8-K detailing material agreements, acquisition completion, new debt, and equity sales.
AI Summary
On May 5, 2025, Catheter Precision, Inc. entered into a material definitive agreement and completed an acquisition. The company also incurred a direct financial obligation and engaged in unregistered sales of equity securities. These events are detailed in their Form 8-K filing.
Why It Matters
This filing indicates significant corporate actions, including new agreements and acquisitions, which could impact the company's strategic direction and financial performance.
Risk Assessment
Risk Level: medium — The filing involves multiple significant events including new agreements, an acquisition, financial obligations, and equity sales, which carry inherent risks.
Key Players & Entities
- Catheter Precision, Inc. (company) — Registrant
- May 5, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-38677 (identifier) — SEC file number
- 38-3661826 (identifier) — EIN
- Ra Medical Systems, Inc. (company) — Former company name
FAQ
What specific material definitive agreement did Catheter Precision, Inc. enter into?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
What was the nature of the acquisition or disposition of assets?
The filing states the completion of an acquisition or disposition of assets, but the specifics of the transaction are not detailed in the provided text.
What is the direct financial obligation incurred by Catheter Precision, Inc.?
The filing mentions the creation of a direct financial obligation, but the amount and terms are not specified in the provided text.
What were the details of the unregistered sales of equity securities?
The filing reports unregistered sales of equity securities, but the number of shares and the price are not disclosed in the provided text.
What is the significance of the former company name 'Ra Medical Systems, Inc.'?
Ra Medical Systems, Inc. was the former name of Catheter Precision, Inc., with a name change occurring on September 8, 2017.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding Catheter Precision, Inc. (VTAK).